Clin2
NCT07134270Likely a fitRecruiting

Digestive bacteria and infection risk in hospitalized patients

Multi Drug Resistant Organisms

Part of Infections clinical trials.

This study looks at whether patients in the hospital who carry certain resistant bacteria in their gut are more likely to get infections. The goal is to understand the risk so doctors can better protect you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
400 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years old or older.
  • You are currently admitted to one of the participating hospital wards.
  • You can sign a form that says you agree to be in the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05798364Recruiting
Study how resistant gut bacteria spread within households

This study tracks a specific kind of antibiotic-resistant gut bacteria in hospital patients and how it may spread to people living in the same home. It may help researchers understand transmission risk inside households and improve prevention strategies.

Paris, Île-de-France Region
NCT05798351Recruiting
Study bacteria on admission in adults at a hospital

This study looks at bacteria (including antibiotic-resistant germs) present when you are admitted to a hospital. It may help doctors understand how often these germs are carried and how to respond early to prevent spread.

Paris, Île-de-France Region
NCT06511492Not yet recruiting
Tracking resistant bacteria in cirrhosis patients

This study monitors patients with worsening cirrhosis for certain hard-to-treat bacteria in the gut. It aims to understand how these bacteria spread and how to prevent infections.

NCT05835206Recruiting· Phase 2
Drug to reduce antibiotic-resistant gut bacteria

This Phase 2 study tests whether an investigational treatment can help clear or reduce antibiotic-resistant bacteria living in the gut. It may help prevent these germs from causing future infections by targeting specific resistant bacteria found on stool or rectal swabs.

Atlanta, Georgia
NCT05734391Enrolling by invitation
Tracking hospital infections and germs from nose and rectum swabs

This trial monitors healthcare-associated infections and antibiotic resistance by collecting swabs from the nose and rectum while you are hospitalized. It may help doctors better understand how often these infections happen and how to prevent them.

Philadelphia, Pennsylvania
NCT06321536Recruiting· Phase 2
Testing microbiota therapy for resistant bacteria in the gut

This study tests a treatment made from healthy donor stool (called microbiota therapy) given as an enema or through a feeding tube. It aims to help people who carry resistant bacteria that are hard to treat, by reducing or clearing those bacteria from the gut.

Atlanta, Georgia

Hear when a new Multi Drug Resistant Organisms trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.